NanoRepro AG Sustainability Reports
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use. The company's clinical portfolios primarily cover family planning, preventive healthcare lines, and infectious disease detection.
Sector: Manufacturing
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 3912008FCA63AGIMEV74
FIGI: BBG001T3PCJ5
9 reports from 2016 to 2024
